Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
- NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_assertion description "[Immune reactivity to FH was detected in 66.67% of patients with AIH, 19.35% of patients with primary biliary cirrhosis (PBC), 12.31% of patients with chronic hepatitis B (CHB), 6.35% of patients with chronic hepatitis C (CHC), 11.32% of patients with systemic lupus erythematosus (SLE), and 3.57% of normal individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
- NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_assertion evidence source_evidence_literature NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
- NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_assertion SIO_000772 18355017 NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
- NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_assertion wasDerivedFrom befree-20140225 NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
- NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_assertion wasGeneratedBy ECO_0000203 NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP456881.RA5h5MKd-p9KBksfTa9Ja3MU9qv1c19BVTbCUlnC9ZzCo130_provenance.